Browse our complete database | AME

All filters

Slidesets

Emerging swtich strategies in 1st line ART-Paula Munderi

Presented at:

INTEREST 2017

Slidesets

Introducing new options for 1st line ART in RLS- Michelle Moorhouse

Presented at:

INTEREST 2017

Slidesets

Using community-based HIV testing campaigns by lay health workers to identify signs and symptoms of tuberculosis in the Botswana Combination Prevention Project- L.A. Mills

Presented at:

INTEREST 2017

Slidesets

One year outcomes following availability of community-based HIV self-testing: uptake, accuracy and linkage into care in a prospective study in Blantyre, Malawi- A. Choko

Presented at:

INTEREST 2017

Slidesets

Increased risk of treatment failure after low-level viremia in a large cohort of South African HIV-positive patients treated according to WHO guidelines- L. Hermans

Presented at:

INTEREST 2017

Slidesets

Scaling up against the odds - HIV in Nigeria- Sulieman Akanmu

Presented at:

INTEREST 2017

Slidesets

Lesotho’s HIV Viral load scale up plan and how decentralization contributes to meeting the 90-90-90 goal- Mamakhetha Phalatse

Presented at:

INTEREST 2017

Slidesets

Implementation of the HIV “test-and-treat” strategy in Malawi prisons: experience, challenges, and effectiveness- S. Mendelsohn

Presented at:

INTEREST 2017

Slidesets

Dry blood spot/free virus elution HIV viral load – Patient results vs. patient reach - Dorcus Abuya

Presented at:

INTEREST 2017

Slidesets

How to ensure the best results for patients- Tsakani Baloy

Presented at:

INTEREST 2017

Slidesets

Burden of HIV pretreatment drug resistance in Cameroon- G. F. Tchouwa

Presented at:

INTEREST 2017

Slidesets

Linkage to treatment and retention amongst adolescents and young adults in a large antiretroviral treatment program in Nigeria- H. Khamofu

Presented at:

INTEREST 2017

Slidesets

Loss to follow up among newly diagnosed HIV positive pregnant women in the option B+ program in Malawi- M. John

Presented at:

INTEREST 2017

Slidesets

Six month retention among patients initiated under Treat All learning phase in Zimbabwe: implications for national scale up in high prevalence, resource limited settings- K. Webb

Presented at:

INTEREST 2017

Slidesets

CrAg positivity rates reported from a national CD4-reflexed screening programme identify high-risk regions of co-existent HIV/Cryptococcal disease, requiring urgent programmatic focus into care- L. Coetzee

Presented at:

INTEREST 2017

Slidesets

Evaluation of a community defaulter tracing program focused on mothers who accessed the PMTCT option B+ program in Malawi- H. Jere

Presented at:

INTEREST 2017

Slidesets

Moderate to high antiretroviral therapy adherence is optimal for virologic suppression in HIV-positive pregnant and breastfeeding Cameroonian women initiating “Option B+”: A prospective cohort study- P. Atanga

Presented at:

INTEREST 2017

Slidesets

Prevalence and factors associated with antenatal depression among women enrolled in Option B+ PMTCT in Malawi- B. Harrington

Presented at:

INTEREST 2017

Slidesets

Inclusive education for HIV-positive learners in primary schools- O. Gwayi

Presented at:

INTEREST 2017

Slidesets

Stigma, gender inequality and disclosure: impact on adherence- Annemiek de Ruiter

Presented at:

INTEREST 2017

Slidesets

Rate of antiretroviral drug substitution before and after the introduction of tenofovir based regimen in Malawi- B. Chavula

Presented at:

INTEREST 2017

Slidesets

Comparison of HIV-1 viral titre measurements using Plasma and Dried Blood Spots on Cobas AmpliPrep/TaqMan viral load assay Version 2.0 in western Kenya- F. Ogumbo

Presented at:

INTEREST 2017

Slidesets

Short and long term virological failure and HIV drug resistance in Cameroon- A. Aghokeng Fobang

Presented at:

INTEREST 2017

Slidesets

Treatment optimisation: advocate perspectives- Luckyboy Edison Mkhondwane

Presented at:

INTEREST 2017